zolpidem sublingual / Generic mfg. - LARVOL DELTA

Enhancing Memory Consolidation in Older Adults (clinicaltrials.gov) - P4 | N=10 | Terminated | Sponsor: University of California, Irvine | The new lab was not adequately equipped to handle the sleep research and it was too far from the main lab. Funding was running out.

Enrollment change • Trial termination

Drugs for chronic insomnia. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • CNS Disorders • Insomnia • Sleep Disorder

Expanded table: Some oral drugs for chronic insomnia. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • CNS Disorders • Insomnia • Sleep Disorder

Safety and Efficacy of Zolpidem in the Long-Term Treatment of Insomnia (clinicaltrials.gov) - P3 | N=358 | Not yet recruiting | Sponsor: EMS

New P3 trial • CNS Disorders • Insomnia • Sleep Disorder

Daridorexant (Quviviq) for insomnia. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • CNS Disorders • Insomnia • Sleep Disorder

[VIRTUAL] Lipidome signatures of higher BMI and systemic inflammation in pregnant African American women (Fertility 2021) - "Higher levels of lipid species diglyceride(DG) DG(40:5), phosphatidylcholine(PC) PC 16:0, PC(O-47:2), PC(Ox26:0), triglyceride(TG) TG(49:1) TG(49:2), TG(55:6), TG(57:9), TG(64:7), and TG(66:9) were associated with the higher BMI group, whereas PC(O-37:3), PC(Ox22:00), fatty acid(FA) FA23:3, FA23:4, phosphatidylethanolamine(PE) PE(20:0), and PE(30:0) were associated with the lower BMI group... Maternal BMI and inflammatory markers are related to lipidomic profiles and detailed investigation of these markers may lead to identification of the metabolic pathways associated with higher BMI and systemic inflammation among pregnant African American women."

Clinical • Cardiovascular • Diabetes • Genetic Disorders • Immunology • Inflammation • Metabolic Disorders • Obesity • Oncology • CRP • CXCL8 • IL10 • IL6 • TNFA

Aytu BioScience announces first ZolpiMist clinical study results demonstrating more rapid sleep onset with lingual spray zolpidem versus oral tablet (Market Watch) - "Aytu BioScience...announced today the publication of a clinical study in the journal Pharmacy and Pharmacology, demonstrating that ZolpiMist, Aytu BioScience's lingual spray formulation of zolpidem, achieves sleep onset more quickly than the oral tablet form of zolpidem...in patients seeking short-term treatment for insomnia."

Retrospective data